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culture including coagulase-negative staphylococci 
(CONS). 
Supportive care: Antimicrobial prophylaxis consisted of 
oral ciprofloxacin 500 mg q12h from admission. 17 
patients were given cefepime 2g q8h i.v. empirically. 
The pattern of onset of OVS bacteremia is more or 
less the same in both groups but only in the +IDA group 
did the onset of CONS bacteremia equal that of the 
OVS. Only in the +IDA group the mean L/R ratio was 
significantly higher on days 0,7 14 and 21 (p ~0.05) with 
respect to baseline but also on day +2lwith respect to 
the -IDA group. 
Conclusion: Gram-positive bacteremia occurred pre- 
dominantly within the first 2 weeks after transplant 
when gut integrity was perturbed. The onset of OVS 
bacteremia was not influenced by the administration of 
idarubicin although there were markedly more episodes 
of CONS bacteremia when L/R ratios were elevated 
A (i-year surveillance of antimicrobial resistance 
of Pseudomonas aeruginosa to ceftazidime compared 
to other antimicrobials in a cancer hospital 
Irina N. Petoukhova, Natalia V Dmitrieva 
Cancer Research Center of Russia, 
Moscow, Russia 
Resistance patterns of 822 strains of I? aeruginosa iso- 
lated from cancer patients in 1996-2001 were analysed. 
Resistance to widely used antimicrobial-ceftazidime 
(CAZ) - was 29.5% in 1996-1997; 31.5% in 1998-1999 
and 22.3% in 2000-2001 (p~O.Ol-O.001). Decreasing of 
resistance level to CAZ may be explained by increasing 
usage of cefepime (CPM) in the last 2.5 years. Resistance 
of P aeruginosa to CPM in 2000-2001 didn’t differ 
significantly from that of CAZ (17.2% vs 22.3%, 
p >0.05). Imipenem (IMP) in 2000-2001 was significantly 
more active compared to CAZ (12.9% vs 22.3%, 
p<O.OOOl). Higher level of resistance of P aeruginosa 
compared to CAZ was seen in 2000-2001 to cefoperazone 
(49.4% vs 22.3%,pcO.O001), amikacin (43.0% vs 22.3%, 
pcO.OOOl), ciprofloxacin (57.5% vs 22.3%, p<O.OOOl) 
and meropenem (39.3% vs 22.3%,p<O.O001). Resistance 
rate to last three antimicrobials increased during last 6 
years: amikacin-from 16.7% to 43.0%, ciprofloxacin- 
from 28.9% to 57.5%) and meropenem - from 17.8% to 
39.3% (pcO.0001 for all comparisons). Resistance rate 
of I? aeruginosa to CAZ during 2000 and 2001 was the 
highest in ICU compared to all departments of the 
hospital (33.3% vs 22.3%, pcO.01). Higher rate of 
resistant strains of I? aeruginosa was found in 2000-2001 
in bronchoscopic materials (34.3%, ~~0.02) than in 
other ones. Thus, the surveillance data show that only 
three from abovementioned antimicrobials (CAZ, CPM, 
IMP) maintain their activity against I? aeruginosa strains 
isolated from cancer patients in our hospital. Massive 
usage of other antibiotics such as amikacin, ciprofloxacin 
and meropenem resulted in progressive loss of suscepti- 
bility to them. Probably rational restriction policy is 
needed. 
A nosocomial outbreak of Legionella pneumonia 
in a bone marrow transplant unit 
I. Oren,’ ?: Zuckerman, R. Finkelstein 
Infectious Diseases Unit and Department of 
Hematology, Rambam Medical Center 
Nosocomial outbreak of legionella pneumonia caused 
by legionella pneumophila serogroup 3 occurred in 
four patients after bone marrow transplantation for 
hematologic malignancies in a new bone marrow 
transplantation (BMT) unit during a period of two 
weeks (18/6/00-2/7/00). Diagnosis was established by 
culture of bronchoalveolar lavage (BAL) fluid. Legionella 
pneumophila serogroup 3 was recovered from the water 
supply system to the same unit just before the outbreak. 
Serologic screening revealed no other cases of legionella 
pneumonia in 19 consecutive BMT patients hospitalized 
in the same unit at the same time, giving a frequency of 
infection of 17%. Immediately after the outbreak was 
recognized, tap water use was forbidden, and cipro- 
floxacin prophylaxis was started for all patients in the 
unit, until decontamination of the water was achieved 
by hyperchlorination and superheating. No further 
cases were detected. Later on two more nosocomially 
acquired sporadic cases occurred, on ll/OO and 2/01, 
along with reemergence of legionella in the water. 
Conclusion: Contamination of hospital water supply 
system with legionella carries a high risk for legionella 
pneumonia among BMT patients. Early recognition of 
the outbreak, immediate restrictions over water use, 
antibiotic prophylaxis for all non-infected patients, and 
water decontamination, successfully terminated the out- 
break. Permanent (as opposed to intermittent) decon- 
tamination measures should be taken in order to prevent 
nosocomial legionella pneumonia in high risk patients. 
Rapid disk urease test for detection of Helicobacter 
pylori infection in immunocompromised patients 
K. Ivanova, M. Marina, B Vladimirov, J. Churchev, 
I. Tersiev 
National Center of Infectious and Parasitic Diseases, 
Clinical Center of Gastroenterology, Medical 
University, Sofia, Bulgaria 
The aim of the study was to investigate the incidence of 
isolation of H. pylori in immunocompromised patients 
with gastrointestinal disorders using a rapid disk urease 
test and comparing its accuracy with other methods. 
Methods: 108 patients with MALT lymphomas /45/, 
gastric cancer /36/ and others /27 over the age of 65 were 
studied. Two biopsy specimens for each patient were 
taken from gastric antrum and corpus and were tested 
for H. pylori. By culture, histology and by the rapid disk 
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urease test from one minute to one hour reading of the 
results. A serological test was carried out as well with a 
serum from all f the 108 patients. 
Results: Using culture and or histology as a gold 
standard we found H. pylori in 93 (86%) of the patients 
with 100% of isolation in patients with MALT lym- 
phoma. The sensitivity, specificity predictive positive 
value, predictive negative value and diagnostic accuracy 
of the tests were as follows; rapid disk urease test - 93%; 
100%; 100%; 82%; and 94.3%; histology - 81.1%; 100%; 
100%; 70%; and 82.5%; culture - 76.9%; 100%; 100%; 
75%; and 78.6%; and serology - 82.2%; 88.2%; 100%; 
57%; and 66.8%. 
Conclusion: Our results show an extremely high per- 
centage of isolation of II. pylori immunocompromised 
patients, especially in MALT lymphomas. We conclude 
also that the rapid disk urease test is a quick and 
inexpensive method with a good sensitivity, specificity 
and accuracy for detection of H. pylori infections. 
Antibiotic utilization for pediatric inpatients: 
retrospective study in Department of Pediatrics, 
University of Padua 
E. M. Ruga, F Fregonese, I? Facchin, R. D’Elia, 
Department of Pediatrics, University of Padua” 
Introduction: Antibiotic resistance among common 
pathogenic bacteria in communities has been identified 
as an emerging threat to public health. Surveillance 
programs are useful to reduce the spreading of these 
pathogens. In order to arrange antibiotic policies 
detailed knowledge of prescribing patterns both in in- 
and out-patients is necessary. 
Objective: This study aims to analyze the use of 
antimicrobials in inpatient children admitted to our 
department in Padua. We evaluated antimicrobial use 
including patients’ characteristics, type of antimicrobial, 
the route of administration. 
Methods: In this retrospective study all inpatients 
recovered during January 1999 were analyzed. All 
pediatric services were considered, both internistic 
(general pediatric, oncohematology, nephrology, neo- 
natal pathology, intensive care unit) surgical (pediatric 
surgery) and emergency. We collected information from 
patients records, with regard to antibiotic prescription 
(generic class, dose, duration, route). 
Results: A total of 426 patients were admitted in the 
study, among them 218 (52%) had at least one antibiotic 
prescription. 95 % of oncohematology patients received 
antibiotics, 85% of those in the intensive care unit and 
66% of nephrologic inpatients including transplanted 
patients. On the other side only 20% of emergency 
patients and 33% of general pediatric inpatients 
received antibiotics. The most prescribed antibiotic 
classes were cephalosporins III generation (20%), 
aminopenicillins (15%) and aminoglycosides (14%).The 
route of administration most used was i.v. (68% of all 
prescriptions), especially for patients of intensive care 
unit (88%) and the neonatal service (91%). Only one 
antibiotic course was prescribed in 60% of cases, while 
two or more were given in 40%. The therapy was 
administered for a longer period in the oncohematology 
(median length of therapy 7 days) and intensive care 
units (5 days). 
Discussion: In this study, similarly to studies found in 
literature, a high percentage of inpatients (1:2) received 
antibiotics, especially broad spectrum drugs. The large 
use of these drugs, is explained by the type of patients 
considered: patients with a high risk of infections, 
frequently in oncohematology or in intensive care units. 
Anyway antibiotics were used also in infants with high 
respiratory tract-infections, without a documented 
bacterial etiology. 
INFECTIONS IN ORGAN TRANSPLANT 
PATIENTS 
Intense cytomegalovirus (CMV) prophylaxis reduces 
rejection in orthotopic liver transplantation (OLT) 
Richard Freeman, Michelle Slifkin, Robin Ruthazer, 
Abigail Mithoefer, Mike Angelis, Richard Rohrer, 
Dan Pratt, David R. Snydman 
TransplantOnfectious Diseases, New England Medical 
Center* Boston, MA USA 
Background: CMV disease has been shown to be an 
independent predictor of rejection in OLT. However, 
prevention of CMV disease through use of intense CMV 
prophylaxis has not been demonstrated to reduce rates 
of rejection in liver transplantation. 
Methods: We undertook an analysis to examine the 
impact of intense CMV prophylaxis on rates of biopsy 
proven rejection comparing two eras comprising 191 
consecutive OLT recipients. In the 1994-96 cohort, two 
weeks of IV ganciclovir plus CMV immune globulin 
(CMVIG) was primary prophylaxis for high risk (CMV 
seropositive donor) patients all others received high 
dose acyclovir; in the 1997-99 cohort, all OLT recipients 
received 3 months of oral ganciclovir and CMVIG was 
added for high risk patients. Retrospective review of 
prospectively collected data was analyzed using survival 
analysis and Cox proportional hazard models. 
Results: Comparison of both cohorts showed significant 
reductions of mortality (12% versus 3.3% at one year, 
p=O.O4),rejection (63% versus 43%,p<O.O1) and CMV 
disease (19% vs. 3.3%,p<O.O1) in comparing the 1994-6 
to the 1997-1999 cohorts, respectively. In a multivariate 
analysis of risk factors for biopsy proven rejection, 
absence of ganciclovir prophylaxis (Relative Risk (RR): 
1.83,95% CI 1.17 to 2.85,pcO.Ol),bacteremia (RR:2.57, 
95% CI 1.57 to 4.22,p<O.Ol),initial immunosuppression 
which was cyclosporine based (RR: 1.98, 95% CI 1.26 
to 3.11, p<O.Ol), and biliary anastomosis using a 
choledochojejunostomy (RR: 1.67, 95% CI 0.99 to 
